Two D2C beauty brands, same revenue. One's worth 3x sales, the other 7x.

Two D2C beauty brands doing the same revenue. One is valued at three times sales, the other at seven. Same category, same top line — more than double the price tag. A few years ago that gap didn't exist.

Back then, if you were growing fast, you got the multiple. Growth was the whole story: hit the revenue, and the valuation followed almost mechanically. That isn't true anymore, and the brands being repriced downward are mostly the ones that didn't notice the rule had changed.

The number quietly doing the sorting now

What separates the 3x brand from the 7x brand isn't how fast either is growing. It's the margin left after everything that scales with each order — what's left of a sale once you've paid for the product, for the ad that brought the customer in, and for shipping the order to their door. In unit-economics language, that's the CM2 line.

It helps to see the whole ladder, because the layers get used loosely and it matters which one you mean:

CM2 is the one capital is underwriting today, because it answers the only question that matters before scale: does a single order make money on its own, after you've paid to win the customer and paid to deliver to them? If the answer is no, nothing downstream fixes it.

Why gross margin lies

Gross margin used to be the glamour metric, and it's still the one most brands lead with in a pitch. The problem is you can run a beautiful 70% gross margin and still lose money on every single order. Gross margin only knows about the product. It says nothing about the two costs that actually sink beauty brands: what you paid to acquire the customer, and what it costs to get a small parcel to their door and absorb the ones that come back.

A worked example

Take an illustrative ₹1,000 order at a 70% gross margin. That throws off ₹700 of product margin — the number that looks great on a slide. Now run it through CM2. Acquiring or re-targeting that customer costs, say, ₹400 on a blended basis. Picking, packing, shipping, payment fees and returns cost another ₹250. The ₹700 is now ₹50. Push acquisition to ₹500 in a competitive category — entirely normal in beauty — and CM2 goes negative. The brand is losing money on every order while reporting a 70% gross margin. Same headline, opposite business.

That's the gap a valuation multiple is now pricing. The 7x brand is the one whose CM2 is clearly, durably positive without buying every customer. The 3x brand is the one whose growth was real but whose unit never stood on its own.

And the environment is enforcing it

This isn't only a change of taste among investors — the funding environment is making the call for them. Beauty and personal-care funding peaked around 2021 and has fallen hard since. The rounds that do happen are fewer and larger, and they're pointed at brands that can prove the unit already works. When capital was cheap and abundant, a negative CM2 was a growth expense you'd fix later. When capital is scarce, a negative CM2 is just a faster way to run out of money.

What it changes from the finance seat

This flips the entire spend conversation inside a brand. When capital paid for growth, the question in every meeting was "how fast can we grow this." When capital pays for durability, it becomes "what's the smallest version of this that makes money without us buying every customer."

In practice, that changes what you defend. You stop defending blended numbers that average a profitable cohort with a subsidised one. You start defending the cohort that comes back without being re-targeted — the customers who return at near-zero acquisition cost, which is the only thing that makes a positive CM2 durable rather than a one-quarter accident. You kill the SKU that only moves at a discount, and the channel that only works while you're paying to sit on it. None of that shows up on a growth chart. All of it shows up in CM2.

If CM2 is negative, no cheque fixes it — a bigger round just lets you lose money faster, on more orders. That's the sentence worth keeping. The job isn't to grow the loss; it's to make the unit solvent, then grow it.

Whether this is the market finally pricing durability the way it always should have, or just the polite word for a market that ran out of patience, I'm not sure — and the honest answer is probably both, right up until cheap money returns and tests it. But a brand built to a real CM2 line doesn't need to know which it is. It's solvent in either world. That, in the end, is the whole case for the number: it's the one metric that doesn't depend on the funding environment staying kind.

The 3x / 7x multiple spread and the 70% gross margin used here are illustrative framing to make the mechanic concrete, not claims about specific named companies. The funding trend — beauty and personal-care investment peaking around 2021 and falling since — is directional, drawn from public funding data.

Common questions

What is CM2 (contribution margin 2)?

CM2 is what's left of a sale after every cost that scales with the order: the product itself (CM1, close to gross margin), the performance marketing that acquired the customer, and the cost of shipping, payment and returns. It tells you whether a single order makes money on its own, before any scale.

What's the difference between CM1, CM2 and CM3?

CM1 is revenue minus the cost of the product. CM2 then subtracts the variable cost of getting and fulfilling the order — performance marketing, shipping, payment and returns. CM3 subtracts the remaining variable overhead. CM2 is the line capital underwrites today.

Why can a brand with a 70% gross margin still lose money?

Gross margin only knows the product cost. A ₹1,000 order at 70% gross margin throws off ₹700, but subtract roughly ₹400 to acquire the customer and ₹250 to ship and absorb returns and you're at ₹50 — and a higher acquisition cost pushes CM2 negative. The brand loses money on every order while reporting a beautiful gross margin.

Related reading

How to read a D2C brand's quarterly

Reading Urban Company's FY26

The line that carries Zepto's filing